Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Inflammatory Bowel Diseases

  Free Subscription


17.10.2022

7 Aliment Pharmacol Ther
3 Am J Gastroenterol
1 Clin Gastroenterol Hepatol
2 Gastroenterol Hepatol
1 Gastroenterology
5 Gut
1 Inflamm Bowel Dis
1 J Clin Gastroenterol
5 J Crohns Colitis
1 J Pediatr
1 Lancet Gastroenterol Hepatol
1 Mediators Inflamm
1 PLoS Genet
1 Scand J Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. EVERHOV AH, Olen O
    Editorial: colorectal cancer in elderly-onset IBD-what is the risk? Authors' reply.
    Aliment Pharmacol Ther. 2022;56:1423-1424.
    PubMed        

  2. WEISS A, Buchner AM
    Editorial: colorectal cancer in elderly-onset inflammatory bowel disease-what is the risk?
    Aliment Pharmacol Ther. 2022;56:1421-1422.
    PubMed        

  3. LEE KE, Faye AS
    Letter: fighting the battle but losing the war-inflammatory bowel disease and venous thromboembolism. Authors' reply.
    Aliment Pharmacol Ther. 2022;56:1427-1428.
    PubMed        

  4. SAHYOUN L, Dahiya DS, Cheng CI, Sultan K, et al
    Letter: fighting the battle but losing the war-inflammatory bowel disease and venous thromboembolism.
    Aliment Pharmacol Ther. 2022;56:1425-1426.
    PubMed        

  5. BEZZIO C, Alimenti E, Saibeni S
    Letter: immune-mediated inflammatory diseases and inflammatory bowel disease-are we ready for a Copernican revolution?
    Aliment Pharmacol Ther. 2022;56:1429-1430.
    PubMed        

  6. DAHL EK, Abed OK, Kjeldsen J, Donia M, et al
    Safety and efficacy of infliximab and corticosteroid therapy in checkpoint inhibitor-induced colitis.
    Aliment Pharmacol Ther. 2022;56:1370-1382.
    PubMed         Abstract available

  7. NORGARD BM, Friedman S, Kjeldsen J, Nielsen J, et al
    The safety of paternal and maternal use of 5-aminosalicylic acid during conception and pregnancy: a nationwide cohort study.
    Aliment Pharmacol Ther. 2022;56:1349-1360.
    PubMed         Abstract available


    Am J Gastroenterol

  8. FAIRBRASS KM, Guthrie EA, Black CJ, Selinger CP, et al
    Characteristics and Impact of Anxiety and Depression Trajectories in Inflammatory Bowel Disease.: Anxiety and Depression Trajectories in IBD.
    Am J Gastroenterol. 2022 Oct 12. pii: 00000434-990000000-00552.
    PubMed         Abstract available

  9. EGBERG MD, Zhang X, Smitherman AB, Kappelman MD, et al
    LOW RISK OF LYMPHOMA IN PEDIATRIC PATIENTS TREATED FOR INFLAMMATORY BOWEL DISEASE.
    Am J Gastroenterol. 2022 Oct 10. pii: 00000434-990000000-00543.
    PubMed         Abstract available

  10. DONG J, Ladonne M, Feuerstein JD
    Medicare Patients Face High Out-of-Pocket Costs for Specialty Inflammatory Bowel Disease Medications.
    Am J Gastroenterol. 2022 Oct 10. pii: 00000434-990000000-00549.
    PubMed         Abstract available


    Clin Gastroenterol Hepatol

  11. CHANG HC, Gau SY
    Inflammatory Bowel Disease and Incident Acute Arterial Events.
    Clin Gastroenterol Hepatol. 2022 Oct 8. pii: S1542-3565(22)00927.
    PubMed        


    Gastroenterol Hepatol

  12. LADRON ABIA P, Alonso N, Minguez Sabater A, Gimeno Torres M, et al
    The characteristics of the stricture, but not the ongoing treatment, could influence the outcome of endoscopic dilation in recurrent Crohn's disease.
    Gastroenterol Hepatol. 2022;45:614-620.
    PubMed         Abstract available

  13. WAH-SUAREZ MI, Vazquez MAM, Bosques-Padilla FJ
    Inflammatory bowel disease: The role of commensal microbiome in immune regulation.
    Gastroenterol Hepatol. 2022;45:626-636.
    PubMed         Abstract available


    Gastroenterology

  14. PALMELA C, Maaser C
    The use of intestinal ultrasound in ulcerative colitis - more than a mucosal disease?
    Gastroenterology. 2022 Oct 9. pii: S0016-5085(22)01161.
    PubMed        


    Gut

  15. WARD D, Andersson M, Nyboe Andersen N, Allin KH, et al
    Risk of acute arterial events associated with treatment of inflammatory bowel diseases: a nationwide Danish cohort study.
    Gut. 2022;71:2373-2374.
    PubMed        

  16. HUO X, Li D, Wu F, Li S, et al
    Cultivated human intestinal fungus Candida metapsilosis M2006B attenuates colitis by secreting acyclic sesquiterpenoids as FXR agonists.
    Gut. 2022;71:2205-2217.
    PubMed         Abstract available

  17. ROSATI E, Rios Martini G, Pogorelyy MV, Minervina AA, et al
    A novel unconventional T cell population enriched in Crohn's disease.
    Gut. 2022;71:2194-2204.
    PubMed         Abstract available

  18. SCHIEPATTI A, Sanders DS, Baiardi P, Caio G, et al
    Nomenclature and diagnosis of seronegative coeliac disease and chronic non-coeliac enteropathies in adults: the Paris consensus.
    Gut. 2022;71:2218-2225.
    PubMed         Abstract available

  19. NEWMAN KL, Jencks K, Chedid V, Paul S, et al
    Response to Mansoor et al: 'epidemiology of inflammatory bowel disease in men with high-risk homosexual activity'.
    Gut. 2022 Oct 13. pii: gutjnl-2022-328802. doi: 10.1136/gutjnl-2022-328802.
    PubMed        


    Inflamm Bowel Dis

  20. BREUGELMANS T, Arras W, Boen LE, Borms E, et al
    Aberrant Mucin Expression Profiles Associate With Pediatric Inflammatory Bowel Disease Presentation and Activity.
    Inflamm Bowel Dis. 2022 Oct 14. pii: 6761121. doi: 10.1093.
    PubMed         Abstract available


    J Clin Gastroenterol

  21. GREYWOODE R, Cunningham C, Hollins M, Aroniadis O, et al
    Medical Cannabis Use Patterns and Adverse Effects in Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2022 Oct 14. pii: 00004836-990000000-00077.
    PubMed         Abstract available


    J Crohns Colitis

  22. FOLLIN-ARBELET B, Milada SC, Hovde O, Jelsness-Jorgensen LP, et al
    Mortality in patients with Inflammatory Bowel Disease: Results from 30 years of follow-up in a Norwegian inception cohort (the IBSEN study).
    J Crohns Colitis. 2022 Oct 14. pii: 6761119. doi: 10.1093.
    PubMed         Abstract available

  23. VIEUJEAN S, Moens A, Hassid D, Rothfuss K, et al
    Pneumocystis jirovecii pneumonia in patients with inflammatory bowel disease - A case series.
    J Crohns Colitis. 2022 Oct 12. pii: 6759599. doi: 10.1093.
    PubMed         Abstract available

  24. OTERO-PINEIRO AM, Jia X, Pedersen KE, Hull T, et al
    Surgical Intervention is Effective for the Treatment of Crohn's related Rectovaginal Fistulas: Experience From A Tertiary Inflammatory Bowel Disease Practice.
    J Crohns Colitis. 2022 Oct 11. pii: 6758392. doi: 10.1093.
    PubMed         Abstract available

  25. BAHNAM P, Hanzel J, Ma C, Zou L, et al
    Most placebo-controlled trials in inflammatory bowel disease were underpowered because of overestimated drug efficacy rates: Results from a systematic review of induction studies.
    J Crohns Colitis. 2022 Oct 11. pii: 6758390. doi: 10.1093.
    PubMed         Abstract available

  26. NYSTROM N, Prast-Nielsen S, Correia M, Globisch D, et al
    Mucosal and plasma metabolomes in new-onset paediatric inflammatory bowel disease: correlations with disease characteristics and plasma inflammation protein markers.
    J Crohns Colitis. 2022 Oct 11. pii: 6758389. doi: 10.1093.
    PubMed         Abstract available


    J Pediatr

  27. GUPTA N, Lustig RH, Andrews H, Guthery SL, et al
    Sex-Specific Pathways Lead to Statural Growth Impairment in Children with Crohn's Disease.
    J Pediatr. 2022;249:75-83.
    PubMed         Abstract available


    Lancet Gastroenterol Hepatol

  28. NOOR NM, Siegel C
    Partially randomised, patient preference trials for inflammatory bowel disease.
    Lancet Gastroenterol Hepatol. 2022;7:981-983.
    PubMed        


    Mediators Inflamm

  29. LIU J, Shi L, Huang W, Zheng Z, et al
    Homoharringtonine Attenuates Dextran Sulfate Sodium-Induced Colitis by Inhibiting NF-kappaB Signaling.
    Mediators Inflamm. 2022;2022:3441357.
    PubMed         Abstract available


    PLoS Genet

  30. KARAKY M, Boucher G, Mola S, Foisy S, et al
    Prostaglandins and calprotectin are genetically and functionally linked to the Inflammatory Bowel Diseases.
    PLoS Genet. 2022;18:e1010189.
    PubMed         Abstract available


    Scand J Gastroenterol

  31. SHIGA H, Takahashi T, Shiraki M, Kojima Y, et al
    Reduced antiviral seropositivity among patients with inflammatory bowel disease treated with immunosuppressive agents.
    Scand J Gastroenterol. 2022 Oct 12:1-8. doi: 10.1080/00365521.2022.2132831.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: